Fetalix reaches 1000 followers on LinkedIn

Scientific innovation thrives through collaboration, communication, and the exchange of knowledge. Building an engaged community around emerging technologies is an important part of fostering dialogue with researchers, clinicians, industry partners, and the broader innovation ecosystem.

Fetalix has reached the milestone of 1000 followers on LinkedIn, reflecting the growing interest in the company's mission. Since its launch, the company's digital presence has provided a platform to share research progress, technological developments, and key milestones in its journey from academic research to biotechnology venture.

Reaching this milestone represents an opportunity to strengthen connections with an international community and to increase the visibility of the scientific and technological advances driving Fetalix's work. Through continued engagement, the company aims to promote knowledge exchange and foster collaborations that support the translation of innovation into clinical impact.

Fetalix thanks its growing community for its interest and support and looks forward to continuing to share the next stages of its development.

February 12, 2025